SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-085664
Filing Date
2022-08-03
Accepted
2022-08-03 16:33:53
Documents
2
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222416-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2222416-2_3seq1.xml 3 1590
2 EXHIBIT 24 tm2222416d2_ex24.htm EX-24 10051
  Complete submission text file 0001104659-22-085664.txt   13060
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVENUE THERAPEUTICS, INC. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NC 10014
Business Address
MacLean Alexandra (Reporting) CIK: 0001940880 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38114 | Film No.: 221133172